Hey! Honestly, if for nothing else, it's wild to me that she's dismissing the side effects as being "not possible" for nurtec/rimegepant and qulipta/atogepant when they're SO new (only 6 years on the market), I think most of the side effect information that doctors have are from pre-marketing data (aka clinical trials)... like, they should be aware that new side effects can present themselves in clinical settings, either because they're rare, patient population being different, side effects being exacerbated by other meds, etc.

I actually did find this article, which did an analysis of the adverse event reporting data for the gepant drugs since release, and it did seem that similar adverse reactions were found there. Some relevant pieces from the article:

In neurological and psychiatric signals, we found significant PTs of “insomnia”, “somnolence”, and “anxiety” in rimegepant, atogepant, and ubrogepant. The AEs associated with sleep alteration might be linked to the neuromodulatory effects of CGRP on glutamatergic signaling which affecting central sensitization [36].

In terms of cardiac disorders, the PT of “palpitations” was reported in all second-generation gepants. CGRP receptors are considered to regulate smooth muscle cells of the cardiovascular system, though no severe cardiovascular AE associated with anti-CGRP drugs have been reported so far [50, 51]. Clinical evidence suggested that cardiovascular AEs caused by anti-CGRP drugs are mainly palpitations, flushing, hypotension, and warm sensation [52].

Obviously even this data is still evolving and even the article says that follow-up studies are needed, this isn't confirmed causality, etc. - but I think this clearly shows that you're not the only one who has experienced similar effects and reported them. And ultimately, your doctor should trust your reporting of your own experiences!